Frazier Healthcare Partners, or Frazier Management LLC, raised over $617 million for Frazier Life Sciences X LP.

The oversubscribed fund will mainly target therapeutics-focused companies that develop and commercialize biopharmaceuticals.

It will invest in company creation, early-stage venture and late-stage private or public opportunities, with two-thirds of its capital to be allocated in seed and series A financing rounds.